4//SEC Filing
Sheng Morgan 4
Accession 0001209191-20-038059
CIK 0001714798other
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 6:39 PM ET
Size
5.6 KB
Accession
0001209191-20-038059
Insider Transaction Report
Form 4
Sheng Morgan
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-06-17+17,000→ 17,000 totalExercise: $16.98Exp: 2030-06-17→ Common Stock (17,000 underlying)
Footnotes (1)
- [F1]This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) June 17, 2021 and (ii) the date immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date.
Documents
Issuer
Prevail Therapeutics Inc.
CIK 0001714798
Entity typeother
Related Parties
1- filerCIK 0001793833
Filing Metadata
- Form type
- 4
- Filed
- Jun 18, 8:00 PM ET
- Accepted
- Jun 19, 6:39 PM ET
- Size
- 5.6 KB